Immunocytochemistry and integration of RAGE immunofluorescence prior to and 24 h after administration of sub-toxic doses of 10 and 20 μM p-BrBzGSH(Cp)2 were used to examine protein levels in GBM cells (Figure 4C). Here, AGER is linked to glioblastoma.